197
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Safety and pharmacokinetic studies of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol or γ-tocopherol in beagle dogs

, , , , &
Pages 419-431 | Received 07 Oct 2012, Accepted 04 Feb 2013, Published online: 25 Apr 2013

References

  • Alberts DS, Garcia DJ. (1997). Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs 54:30–5
  • Alipour M, Omri A, Smith MG, Suntres ZE. (2007). Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries. J Endotoxin Res 13:297–304
  • Alipour M, Smith MG, Pucaj K, Suntres ZE. (2012). Acute toxicity study of liposomal antioxidant formulations containing N-acetylcysteine, alpha-tocopherol, and gamma-tocopherol in rats. J Liposome Res 22:158–67
  • Allen TM. (1998). Liposomal drug formulations: rationale for development and what we can expect for the future. Drugs 56:747–56
  • Beg S, Javed S, Kohli K. (2010). Bioavailability enhancement of coenzyme Q10: an extensive review of patents. Recent Pat Drug Deliv Formul 4:245–55
  • Benzie IF. (2000). Evolution of antioxidant defence mechanisms. Eur J Nutr 39:53–61
  • Buonocore C, Alipour M, Omri A, et al. (2011). Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine. J Drug Target 19:821–9
  • Carnemolla R, Shuvaev VV, Muzykantov VR. (2010). Targeting antioxidant and antithrombotic biotherapeutics to endothelium. Semin Thromb Hemost 36:332–42
  • Chanan-Khan A, Szebeni J, Savay S, et al. (2003). Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 14:1430–7
  • Evans P, Halliwell B. (2001). Micronutrients: oxidant/antioxidant status. Br J Nutr 85:S67–74
  • Fan J, Shek PN, Suntres ZE, et al. (2000). Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery 128:332–38
  • Freeman BA, Turrens JF, Mirza Z, et al. (1985). Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. Fed Proc 44:2591–5
  • Gregoriadis G. (1991). Overview of liposomes. J Antimicrob Chemother 28:39–48
  • Lyass O, Uziely B, Ben-Yosef R, et al. (2000). Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer 89:1037–47
  • McClintock SD, Hoesel LM, Das SK, et al. (2006). Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 26:126–31
  • McCord JM. (2000). The evolution of free radicals and oxidative stress. Am J Med 108:652–9
  • Minko T, Stefanov A, Pozharov V. (2002). Selected contribution: lung hypoxia: antioxidant and antiapoptotic effects of liposomal alpha-tocopherol. J Appl Physiol 93:1550–60
  • Mitsopoulos P, Omri A, Alipour M, et al. (2008). Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. Int J Pharm 363:106–11
  • Mukherjee S, Stone WL, Yang H, et al. (2009). Protection of half sulfur mustard gas-induced lung injury in guinea pigs by antioxidant liposomes. J Biochem Mol Toxicol 23:143–53
  • Muzykantov VR. (2001a). Delivery of antioxidant enzyme proteins to the lung. Antioxid Redox Signal 3:39–62
  • Muzykantov VR. (2001b). Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 71:1–21
  • Ratnam DV, Ankola DD, Bhardwaj V, et al. (2006). Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 113:189–207
  • Riccardi A, Brugnatelli S, Danova M, et al. (2006). Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study. Tumori 92:6–12
  • Sies H. (1997). Oxidative stress: oxidants and antioxidants. Exp Physiol 82:291–5
  • Sinha J, Das N, Basu MK. (2001). Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain. Biomed Pharmacother 55:264–71
  • Steinhubl SR. (2008). Why have antioxidants failed in clinical trials? Am J Cardiol 101:14D–19D
  • Stone WL, Smith M. (2004). Therapeutic uses of antioxidant liposomes. Mol Biotechnol 27:217–30
  • Storm G, Wilms HP, Crommelin DJ. (1991). Liposomes and biotherapeutics. Biotherapy 3:25–42
  • Suntres ZE. (2002). Role of antioxidants in paraquat toxicity. Toxicology 180:65–77
  • Suntres ZE. (2011). Liposomal Antioxidants for protection against oxidant-induced damage. J Toxicol. doi: 10.1155/2011/152474
  • Suntres ZE, Shek PN. (1994). Incorporation of alpha-tocopherol in liposomes promotes the retention of liposome-encapsulated glutathione in the rat lung. J Pharm Pharmacol 46:23–8
  • Suntres ZE, Shek PN. (1995). Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes. J Drug Target 3:201–8
  • Suntres ZE, Shek PN. (1996). Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Shock 6: S57–64
  • Suntres ZE, Shek PN. (1997). Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury. Biomed Environ Sci 10:47–59
  • Suntres ZE, Shek PN. (1998). Prophylaxis against lipopolysaccharide-induced acute lung injury by alpha-tocopherol liposomes. Crit Care Med 26:723–9
  • Szebeni J, Alving CR, Rosivall L, et al. (2007). Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res 17:107–17
  • Szebeni J, Fontana JL, Wassef NM, et al. (1999). Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 99:2302–9
  • Torchilin VP. (2006). Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 8:343–75
  • Turrens JF, Crapo JD, Freeman BA. (1984). Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 73:87–95
  • Udhrain A, Skubitz KM, Northfelt DW. (2007). Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma. Int J Nanomedicine 2:345–52
  • Urano S, Kitahara M, Kato Y, et al. (1990). Membrane stabilizing effect of vitamin E: existence of a hydrogen bond between alpha-tocopherol and phospholipids in bilayer liposomes. J Nutr Sci Vitaminol (Tokyo) 36:513–19
  • Verdon CP, Blumberg JB. (1988). Influence of dietary vitamin E on the intermembrane transfer of alpha-tocopherol as mediated by an alpha-tocopherol binding protein. Proc Soc Exp Biol Med 189:52–60
  • Ward PA. (2010). Oxidative stress: acute and progressive lung injury. Ann N Y Acad Sci 1203:53–9
  • Werner C, Wendel A. (1990). Hepatic uptake and antihepatotoxic properties of vitamin E and liposomes in the mouse. Chem Biol Interact 75:83–92
  • Yang XL, Ma HX, Yang ZB, et al. (2006). Comparison of minimum alveolar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs. Anesthesiology 104:482–7
  • Ziech D, Franco R, Georgakilas AG, et al. (2010). The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact 188:334–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.